Optimizing Your Clinical Supply Chain Strategy For Asia-Pacific Studies
Summary: Unlike Europe where clinical trial regulations are largely standardized between the EMEA member states, no such organization or harmonization exists in the APAC region, making conducting multi-country studies within the region much more complex for clinical sponsors, particularly with regards to the sourcing, packaging and distribution of clinical supplies. Practical considerations including infrastructure availability and quality, language barriers, cultural business norms and local product availability can and do vary widely within the region adding a further level of complexity for sponsors.
In this webinar we will explore how to leverage the major clinical supply centers of China, Singapore and Japan to support clinical trials within the Asia-Pacific region for both local and global study sponsors. We will explore clinical packaging, logistics and import/export considerations that should be taken into account when developing a clinical supply strategy and why there is no substitute for on-the ground local expertise.